Cardiac biomarkers - A short biography

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 197-200

  Collinson, Paul O ^a   Garrison, Lisa ^a   Christenson, Robert H ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac biomarkers; History of medicine

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; HYDROXYBUTYRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; MYOSIN LIGHT CHAIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ANGINA PECTORIS; CARDIAC TROPONIN 1 CLIA; CLINICAL FEATURE; CORONARY ARTERY; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC VALUE; EDITORIAL; ELECTROCARDIOGRAM; ENZYME ACTIVITY; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN DEATH; BLOOD; CARDIOVASCULAR DISEASES;

BIOMARKERS; CARDIOVASCULAR DISEASES; HUMANS;

EID: 84924554759     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.11.014     Document Type: Editorial

References (56)

1. Herrick J.B. Landmark article (JAMA 1912). Clinical features of sudden obstruction of the coronary arteries. By James B. Herrick. JAMA 1983, 250:1757-1765.
2. Lewis T. Electro-cardiography and its importance in the clinical examination of heart affections. Br Med J 1912, 1:1479-1482.
3. O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 61:e78-e140.
4. Leibowitz J. Introductory survey. The history of coronary heart disease 1970, 14. University of California Press, Berkley and Los Angeles.
5. Ladue J.S., Wroblewski F., Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science 1954, 120:497-499.
6. Karmen A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest 1955, 34:131-133.
7. Karmen A., Wroblewski F., Ladue J.S. Transaminase activity in human blood. J Clin Invest 1955, 34:126-131.
8. Agress C.M., Jacobs H.I., Glassner H.F., Lederer M.A., Clark W.G., Wroblewski F., et al. Serum transaminase levels in experimental myocardial infarction. Circulation 1955, 11:711-713.
9. Phear D., Stirland R. The value of estimating fibrinogen and C-reactive-protein levels in myocardial ischaemia. Lancet 1957, 273:270-271.
10. Wroblewski F., LaDue J.S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955, 90:210-213.
11. Bearn A.G., Vesell E.S. Localization of lactic acid dehydrogenase activity in serum fractions. Proc Soc Exp Biol Med 1957, 94:96-99.
12. Rosalki S.B., Wilkinson J.H. Reduction of alpha-ketobutyrate by human serum. Nature 1960, 188:1110-1111.
13. Elliott B.A., Wilkinson J.H. Serum "alpha-hydroxybutyric dehydrogenase" in myocardial infarction and in liver disease. Lancet 1961, 1:698-699.
14. Konttinen A. Alpha-hydroxybutyric dehydrogenase in the detection of myocardial infarction. Lancet 1961, 2:556.
15. Konttinen A., Halonen P.I. Serum alpha-hydroxybutyric dehydrogenase (HBD) in myocardial infarction. Comparison with glutamic oxalacetic transminase (GOT) and lactic dehydrogenase (LDH). Am J Cardiol 1962, 10:525-531.
16. Dreyfus J.C., Schapira G., Resnais J., Scebat L. Serum creatine kinase in the diagnosis of myocardial infarct. Rev Fr Etud Clin Biol 1960, 5:386-387.
17. Kornberg A. Reversible enzymatic synthesis of diphosphopyridine and inorganic pyrophosphate. J Biol Chem 1950, 182:779-793.
18. Rosalki S.B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967, 69:696-705.
19. Collinson P.O., Rosalki S.B., Flather M., Wolman R., Evans T. Early diagnosis of myocardial infarction by timed sequential enzyme measurements. Ann Clin Biochem 1988, 25(Pt 4):376-382.
20. Collinson P.O., Stubbs P.J. Early 'rule-in' diagnosis of acute myocardial infarction 4h post admission for rapid risk stratification by creatine kinase increment (creatine kinase change). Ann Clin Biochem 1996, 33(Pt 4):308-313.
21. Roberts R., Henry P.D., Witteeveen S.A., Sobel B.E. Quantification of serum creatine phosphokinase isoenzyme activity. Am J Cardiol 1974, 33:650-654.
22. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979, 59:607-609.
23. Kubasik N.P., Guiney W., Warren K., D'Souza J.P., Sine H.E., Brody B.B. Radioimmunoassay of serum myoglobin: evaluation and modification of a commercial kit and assessment of its usefulness for detecting acute myocardial infarction. Clin Chem 1978, 24:2047-2049.
24. Roxin L.E., Venge P., Friman G., Hallgren R. Radioimmunoassays of human myoglobin in serum and urine. Scand J Clin Lab Invest 1979, 39:37-46.
25. Roxin L.E., Venge P., Wide L. A fast and sensitive radioimmunoassay of human myoglobin for use in the early diagnosis of heart infarction. Clin Chim Acta 1980, 107:129-134.
26. Roxin L.E., Cullhed I., Groth T., Hallgren T., Venge P. The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction. Acta Med Scand 1984, 215:417-425.
27. Vaidya H.C., Maynard Y., Dietzler D.N., Ladenson J.H. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin Chem 1986, 32:657-663.
28. Khaw B.A., Fallon J.T., Beller G.A., Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation 1979, 60:1527-1531.
29. Khaw B.A., Gold H.K., Fallon J.T., Haber E. Detection of serum cardiac myosin light chains in acute experimental myocardial infarction: radioimmunoassay of cardiac myosin light chains. Circulation 1978, 58:1130-1136.
30. Cummins P., Young A., Auckland M.L., Michie C.A., Stone P.C., Shepstone B.J. Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomyosin, myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma?. Eur J Clin Invest 1987, 17:317-324.
31. Cummins B., Auckland M.L., Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987, 113:1333-1344.
32. Katus H.A., Remppis A., Looser S., Hallermeier K., Scheffold T., Kubler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989, 21:1349-1353.
33. Hamm C.W., Ravkilde J., Gerhardt W., Jorgensen P., Peheim E., Ljungdahl L., et al. The prognostic value of serum troponin T in unstable angina [see comments]. N Engl J Med 1992, 327:146-150.
34. Galvani M., Ottani F., Ferrini D., Ladenson J.H., Destro A., Baccos D., et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997, 95:2053-2059.
35. Stubbs P., Collinson P., Moseley D., Greenwood T., Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina [see comments]. BMJ 1996, 313:262-264.
36. Ebell M.H., White L.L., Weismantel D. A systematic review of troponin T and I values as a prognostic tool for patients with chest pain. J Fam Pract 2000, 49:746-753.
37. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K.M., Go A.S., Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001, 38:478-485.
38. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
39. Wu A.H., Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M., Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999, 45:1104-1121.
40. Panteghini M., Apple F.S., Christenson R.H., Dati F., Mair J., Wu A.H. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry [see comments]. Clin Chem Lab Med 1999, 37:687-693.
41. Panteghini M., Apple F.S., Christenson R.H., Dati F., Mair J., Wu A.H. Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. Scand J Clin Lab Invest Suppl 1999, 230:103-112.
42. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000, 21:1502-1513.
43. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
44. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. Eur Heart J 2012, 33:2551-2567.
45. Kelley W.E., Januzzi J.L., Christenson R.H. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009, 55:2098-2112.
46. Jesse R.L. On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction. J Am Coll Cardiol 2010, 55:2125-2128.
47. Collinson P.O., Hadcocks L., Foo Y., Rosalki S.B., Stubbs P.J., Morgan S.H., et al. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem 1998, 35(Pt 3):380-386.
48. Melanson S.E., Morrow D.A., Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007, 128:282-286.
49. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
50. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
51. Mills N.L., Churchhouse A.M., Lee K.K., Anand A., Gamble D., Shah A.S., et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011, 305:1210-1216.
52. Collinson P.O., Heung Y.M., Gaze D., Boa F., Senior R., Christenson R., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012, 58:219-225.
53. Koerbin G., Abhayaratna W.P., Potter J.M., Apple F.S., Jaffe A.S., Ravalico T.H., et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem 2013, 46:1636-1643.
54. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
55. de Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
56. Zeller T., Tunstall-Pedoe H., Saarela O., Ojeda F., Schnabel R.B., Tuovinen T., et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014, 35:271-281.